Haemonetics | HAE - Operating Profit

Stock Price
59.92
Daily Change
0.43 0.72%
Monthly
2.27%
Yearly
-8.55%
Q1 Forecast
58.11

Haemonetics reported $67.4M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD 212.8M 72.4M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Hologic USD 237M 16M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Neogen USD -5.38M 10.71M Sep/2025
OraSure Technologies USD -6M 3.26M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Teleflex USD 36.34M 445.24M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
US Physical Therapy USD 16.77M 8.52M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025